Unveiling of world-class laboratory to boost South Africa's pharmaceutical manufacturing capability
South Africa is set to save billions of rands it currently spends on importing active pharmaceutical ingredients (APIs) with the launch of the API Technology Innovation Cluster.
APIs are the biologically active components used to make finished pharmaceutical products such as tablets and capsules, and South Africa's heavy reliance on API imports is one of the factors behind the high cost of health care locally. The country currently spends approximately R15 billion a year on imported APIs.